Introduction to the HESI-Sponsored Inhibin Consortium

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 98, Issue 1, 2013, Pages 1-3

  Chapin, Robert E ^a   Kim, James H ^b  

^a PFIZER INC   (United States)

^b Health and Environmental Sciences Institute   (United States)

Author keywords

Biomarkers; Safety assessment; Spermatogenesis

Indexed keywords

BIOLOGICAL MARKER; CARBENDAZIM; FOLLITROPIN; INHIBIN B;

CLINICAL TRIAL (TOPIC); ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE INFERTILITY; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; SEMINIFEROUS TUBULE; SPERMATOZOON COUNT; TESTIS INJURY;

ANIMALS; ECOLOGY; HEALTH; HUMANS; INHIBINS; MALE; RATS; TESTIS;

EID: 84873429547     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.21048     Document Type: Review

References (27)

1. Adamopoulos DA, Koukkou EG. 2010. Value of FSH and Inhibin B measurements in the diagnosis of azoospermia-a clinician's overview. Int J Androl 33:e109-e113.
2. Allenby G, Foster PMD, Sharpe RM. 1991. Evidence that secretion of immunoactive inhibin by seminiferous tubules from the adult rat testis is regulated by specific germ cell types: correlation between in vivo and in vitro studies. Endocrinol 128:467-476.
3. Anderson RA, Sharpe RM. 2000. Regulation of inhibin production in the human male and its clinical applications. Int J Androl 23:136-144.
4. Byrd W, Bennett MJ, Carr, BR, Dong Y, Wians F, Rainey W. 1998. Regulation of biologically active dimeric Inhibin A and B from infancy to adulthood in the male. J Clin Endocrinol Metab 83:2849-2854.
5. Clifton RJ, O'Donnell L, Robertson DM. 2002. Pachytene spermatocytes in co-culture inhibit rat Sertoli cell synthesis on inhibin βB-subunit and inhibin B but not the inhibin α-subunit. J Endocrinol 172:565-574.
6. Coulson M, Bickerton S, Betts C, Jacobsen M, Stewart J, Chapin RE, Reagan WJ, Alvey J, Erdos Z, Saldutti LP, Sonee M, Bogdan N, Singer M, Vinken P, Barlow V, Czajkowski K, and Kim, JH. 2013. Analytic evaluation of a human ELISA kit for measurement of Inhibin B in rat samples. Birth Def Res Part B XX:YY-ZZ
7. De Kretser DM, Buzzard JJ, Okuma Y, O'Connor AE, Hayashi T, Lin SY, Morrison JR, Loveland KL, Hedger MP. 2004. The role of activin, follistatin and inhibin in testicular physiology. Mol Cell Endocrinol 225:57-64.
8. Ellingsen DG, Chashchin V, Haug E, Chashchin M, Trachenko V, Lubnina N, Bast-Pettersen R, Thomassen Y. 2007. An epidemiological study of reproductive function biomarkers in male welders. Biomarkers 12(5):497-509.
9. Foppiani L, Schlatt S, Simoni M, Weinbauer GF, Hacker-Klom U, Nieschlag E. 1999. Inhibin B is a more sensitive marker of spermatogenic damage than FSH in the irradiated non-human primate model. J Endocrinol 162:393-400.
10. Hild SA, Reel JR, Larner JM, Blye RP. 2001. Disruption of spermatogenesis and Sertoli cell structure and function by the indenopyridine CDB-4022 in rats. Biol Reprod 65:1771-1779.
11. Kamischke A, Simoni M, Schrameyer K, Lerchl A, Nieschlag E. 2001. Is Inhibin B a pharmacodynamic parameter for FSH in normal men? Eur J Endocrinol 144:629-637.
12. Lockwood G. 2004. The diagnostic value of inhibin in infertility evaluation. Sem Repro Med 22(3):195-208.
13. McCullagh DR. 1932. Dual endocrine activity of the testes. Science 76: 19-20.
14. Meachem SJ, Nieschlag E, Simoni M. 2001. Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol 145:561-571.
15. Pfaff T, Rhodes J, Bergmann M, Weinbauer GF. 2013. Inhibin B as a marker of Sertoli cell damage and spermatogenic disturbance in the rat. Birth Def Res XX:YY-ZZ.
16. Pierik FH, Vreeburg JTM, Stijnen T, de Jong FH, Weber RFA. 1998. Serum Inhibin B as a marker for spermatogenesis. J Clin Endocrinol Metab 83:3110-3114.
17. Pineau C, Velez de la Calle JP, Pinon-Lataillade G, Jegou B. 1989. Assessment of testicular function after acute and chronic irradiation: further evidence for an influence of late spermatids on Sertoli cell function in the adult rat. Endocrinology 124:2720-2728.
18. Ramaswamy S, Marshall GR, McNeilly AS, Plant TM. 1999. Evidence that in a physiological setting Sertoli cell number is the major determinant of circulating concentrations of Inhibin B in the adult male rhesus monkey. J Androl 20:430-434.
19. Schrader SM, Turner TW, Breitenstein MJ, Simon SD. 1988. Longitudinal study of semen quality in unexposed workers. Reprod Toxicol 2:183-190.
20. Steinberger A, Steinberger E. 1976. Secretion off an FSH-inhibiting factor by cultured Sertoli cells. Endocrinology 99:918-921.
21. Stewart J, Turner KJ. 2005. Inhibin B as a potential biomarker of testicular toxicity, Cancer Biomark 1:75-91.
22. Suescun MO, Lustig L, Calandra RS, Groome NP, Campo S. 2001. Correlation between inhibin secretion and damage of seminiferous tubules in a model of experimental autoimmune orchitis. J Endocrinology 170:113-120.
23. Tsatsoulis A, Shalet SM, Robertson WR, Morris ID, Burger HG, de Kretser DM. 1988. Plasma inhibin levels in men with chemotherapy-induced severe damage to the seminiferous epithelium. Clin Endocrinol 29:659-665.
24. Tunc L, Kirac M, Gurocak S, Yucel A, Kupeli B, Alkibay T, Bozkirli I. 2006. Can serum Inhibin B and FSH levels, testicular histology, and volume predict the outcome of testicular sperm extraction in patients with non-obstructive azoospermia? Inter Urol Nephrol 38:629-635.
25. Von Eckerdstein S, Simoni M, Bergmann M, Weinbauer GF, Gassner P, Schepers AG, Nieschlag E. 1999. Serum Inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab 84:2496-2501.
26. Wallace EM, Groome NP, Riley SC, Parker AC, Wu FCW. 1997. Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testosterone secretion: a prospective longitudinal study. J Clin Endocrinol Metab 82:3111-3115.
27. Ying SY. 1988. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 9(2):267-293.